inVentiv Health Inc. 

(Public, NASDAQ:VTIV)   Watch this stock   
Find more results for vtiv
Nov 11, 2009
Credit Suisse Healthcare Conference
Nov 5, 2009
Q3 2009 Earnings Conference Call
Nov 4, 2009
Q3 2009 Earnings Release
Sep 22, 2009
UBS Global Life Sciences Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 4.41% -11.38%
Operating margin 9.08% -14.48%
EBITD margin - -11.27%
Return on average assets 4.99% -12.23%
Return on average equity 11.60% -30.46%
Employees 7,100 -

Address

200 Cottontail Lane Vantage Court North
Somerset, NJ 08873
United States - Map
+1-800-4160555 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

inVentiv Health Inc. discussions

  View all discussions »

Description

inVentiv Health Inc. (inVentiv) is a provider of value-added services to the pharmaceutical, life sciences and healthcare industries. The Company supports a range of clinical development, communications and commercialization activities that are critical to its customers' ability to complete the development of drug products and medical devices and commercialize them. In addition, the Company provides medical cost containment services to payors in its patient outcomes business. inVentiv provides services to over 350 client organizations, including all top 20 global pharmaceutical companies, numerous emerging and specialty biotechnology companies, and payors. It operates in four business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes. In December 2008, the Company completed the acquisition of Promotech Logistics Solutions LLC (PLS). In August 2008, the Company completed the acquisition of Patient Marketing Group, LLC (PMG).

Officers and directors

Eran Broshy
Executive Chairman of the Board
Age: 50
Bio & Compensation - Reuters
R. Blane Walter
Chief Executive Officer, Director
Age: 38
Bio & Compensation - Reuters
David S. Bassin
Chief Financial Officer, Secretary
Age: 37
Bio & Compensation - Reuters
A. Clayton Perfall
Director
Age: 50
Bio & Compensation - Reuters
Terrell G. Herring
Director
Portrait. Age: 45
Bio & Compensation - Reuters
Per G. H. Lofberg
Director
Age: 61
Bio & Compensation - Reuters
Mark E. Jennings
Director
Age: 46
Bio & Compensation - Reuters
Craig Saxton M.D.
Director
Age: 66
Bio & Compensation - Reuters